154 related articles for article (PubMed ID: 1609630)
1. Contrasting effects of parathyroid hormone and insulin-like growth factor I in an aged ovariectomized rat model of postmenopausal osteoporosis.
Ibbotson KJ; Orcutt CM; D'Souza SM; Paddock CL; Arthur JA; Jankowsky ML; Boyce RW
J Bone Miner Res; 1992 Apr; 7(4):425-32. PubMed ID: 1609630
[TBL] [Abstract][Full Text] [Related]
2. Temporal expression of the anabolic action of PTH in cancellous bone of ovariectomized rats.
Meng XW; Liang XG; Birchman R; Wu DD; Dempster DW; Lindsay R; Shen V
J Bone Miner Res; 1996 Apr; 11(4):421-9. PubMed ID: 8992872
[TBL] [Abstract][Full Text] [Related]
3. Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength.
Fox J; Miller MA; Newman MK; Metcalfe AF; Turner CH; Recker RR; Smith SY
Calcif Tissue Int; 2006 Oct; 79(4):262-72. PubMed ID: 16969596
[TBL] [Abstract][Full Text] [Related]
4. Effects of recombinant human growth hormone and insulin-like growth factor-I, with or without 17 beta-estradiol, on bone and mineral homeostasis of aged ovariectomized rats.
Verhaeghe J; van Bree R; Van Herck E; Thomas H; Skottner A; Dequeker J; Mosekilde L; Einhorn TA; Bouillon R
J Bone Miner Res; 1996 Nov; 11(11):1723-35. PubMed ID: 8915780
[TBL] [Abstract][Full Text] [Related]
5. Continuous parathyroid hormone and estrogen administration increases vertebral cancellous bone volume and cortical width in the estrogen-deficient rat.
Zhou H; Shen V; Dempster DW; Lindsay R
J Bone Miner Res; 2001 Jul; 16(7):1300-7. PubMed ID: 11450706
[TBL] [Abstract][Full Text] [Related]
6. Combined treatment with a beta-blocker and intermittent PTH improves bone mass and microarchitecture in ovariectomized mice.
Pierroz DD; Bouxsein ML; Rizzoli R; Ferrari SL
Bone; 2006 Aug; 39(2):260-7. PubMed ID: 16531131
[TBL] [Abstract][Full Text] [Related]
7. Parathyroid hormone fragments may stimulate bone growth in ovariectomized rats by activating adenylyl cyclase.
Rixon RH; Whitfield JF; Gagnon L; Isaacs RJ; Maclean S; Chakravarthy B; Durkin JP; Neugebauer W; Ross V; Sung W
J Bone Miner Res; 1994 Aug; 9(8):1179-89. PubMed ID: 7976500
[TBL] [Abstract][Full Text] [Related]
8. Sequential effects of chronic human PTH (1-84) treatment of estrogen-deficiency osteopenia in the rat.
Mitlak BH; Burdette-Miller P; Schoenfeld D; Neer RM
J Bone Miner Res; 1996 Apr; 11(4):430-9. PubMed ID: 8992873
[TBL] [Abstract][Full Text] [Related]
9. An intact N terminus is required for the anabolic action of parathyroid hormone on adult female rats.
Armamento-Villareal R; Ziambaras K; Abbasi-Jarhomi SH; Dimarogonas A; Halstead L; Fausto A; Avioli LV; Civitelli R
J Bone Miner Res; 1997 Mar; 12(3):384-92. PubMed ID: 9076581
[TBL] [Abstract][Full Text] [Related]
10. The influence of combined parathyroid hormone and growth hormone treatment on cortical bone in aged ovariectomized rats.
Andreassen TT; Oxlund H
J Bone Miner Res; 2000 Nov; 15(11):2266-75. PubMed ID: 11092409
[TBL] [Abstract][Full Text] [Related]
11. Parathyroid hormone increases the concentration of insulin-like growth factor-I and transforming growth factor beta 1 in rat bone.
Pfeilschifter J; Laukhuf F; Müller-Beckmann B; Blum WF; Pfister T; Ziegler R
J Clin Invest; 1995 Aug; 96(2):767-74. PubMed ID: 7635970
[TBL] [Abstract][Full Text] [Related]
12. Cancellous and cortical bone architecture and turnover at the iliac crest of postmenopausal osteoporotic women treated with parathyroid hormone 1-84.
Recker RR; Bare SP; Smith SY; Varela A; Miller MA; Morris SA; Fox J
Bone; 2009 Jan; 44(1):113-9. PubMed ID: 18983947
[TBL] [Abstract][Full Text] [Related]
13. Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis.
Li X; Ominsky MS; Warmington KS; Morony S; Gong J; Cao J; Gao Y; Shalhoub V; Tipton B; Haldankar R; Chen Q; Winters A; Boone T; Geng Z; Niu QT; Ke HZ; Kostenuik PJ; Simonet WS; Lacey DL; Paszty C
J Bone Miner Res; 2009 Apr; 24(4):578-88. PubMed ID: 19049336
[TBL] [Abstract][Full Text] [Related]
14. Long-term zoledronic acid treatment increases bone structure and mechanical strength of long bones of ovariectomized adult rats.
Hornby SB; Evans GP; Hornby SL; Pataki A; Glatt M; Green JR
Calcif Tissue Int; 2003 Apr; 72(4):519-27. PubMed ID: 12574877
[TBL] [Abstract][Full Text] [Related]
15. Human parathyroid hormone-(1-34) prevents bone loss and augments bone formation in sexually mature ovariectomized rats.
Liu CC; Kalu DN
J Bone Miner Res; 1990 Sep; 5(9):973-82. PubMed ID: 2281827
[TBL] [Abstract][Full Text] [Related]
16. Effects of progesterone on serum levels of IGF-1 and on femur IGF-1 mRNA in ovariectomized rats.
Barengolts EI; Kouznetsova T; Segalene A; Lathon P; Odvina C; Kukreja SC; Unterman TG
J Bone Miner Res; 1996 Oct; 11(10):1406-12. PubMed ID: 8889839
[TBL] [Abstract][Full Text] [Related]
17. Human parathyroid hormone 1-34 reverses bone loss in ovariectomized mice.
Alexander JM; Bab I; Fish S; Müller R; Uchiyama T; Gronowicz G; Nahounou M; Zhao Q; White DW; Chorev M; Gazit D; Rosenblatt M
J Bone Miner Res; 2001 Sep; 16(9):1665-73. PubMed ID: 11547836
[TBL] [Abstract][Full Text] [Related]
18. Response of cortical bone to antiresorptive agents and parathyroid hormone in aged ovariectomized rats.
Baumann BD; Wronski TJ
Bone; 1995 Feb; 16(2):247-53. PubMed ID: 7756054
[TBL] [Abstract][Full Text] [Related]
19. The effect of ovariectomy and ovarian steroid treatment on growth hormone and insulin-like growth factor-I levels in the rat femur.
Suliman IA; El-Bakri NK; Adem A; Mustafa A; Lindgren JU
J Orthop Res; 2001 Nov; 19(6):1008-12. PubMed ID: 11780998
[TBL] [Abstract][Full Text] [Related]
20. Partial maintenance of extra cancellous bone mass by antiresorptive agents after discontinuation of human parathyroid hormone (1-38) in right hindlimb immobilized rats.
Ma Y; Jee WS; Chen Y; Gasser J; Ke HZ; Li XJ; Kimmel DB
J Bone Miner Res; 1995 Nov; 10(11):1726-34. PubMed ID: 8592950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]